Stock Price
248.80
Daily Change
8.80 3.67%
Monthly
-0.32%
Yearly
-11.27%
Q3 Forecast
245.19

Peers Price Chg Day Year Date
EDAP TMS 2.52 0 0% -18.71% Sep/05
Essilor 259.60 -0.60 -0.23% 22.74% Sep/06
Fresenius Medical Care 41.99 0.28 0.67% 16.83% Sep/06
Fresenius 46.82 -0.36 -0.76% 39.22% Sep/06
Genmab 1,751.50 6.50 0.37% -5.83% Sep/05
Getinge 209.80 0.80 0.38% -3.98% Sep/05
GN Store Nord 114.00 2.50 2.24% -30.85% Sep/05
Lonza 577.40 -0.80 -0.14% 7.68% Sep/05
Philips 23.80 0.02 0.08% -12.63% Sep/06
Pandora 859.60 0.20 0.02% -25.02% Sep/05
Smith & Nephew 1,416.00 6.00 0.43% 18.15% Sep/05
Trinity Biotech 1.16 0.01 0.87% -34.46% Sep/05
Demant 248.80 8.80 3.67% -11.27% Sep/05

Indexes Price Day Year Date
Copenhagen 1557 -16.55 -1.05% -41.56% Sep/05
EU600 549 -0.88 -0.16% 8.42% Sep/05

Demant A/S traded at 248.80 this Friday September 5th, increasing 8.80 or 3.67 percent since the previous trading session. Looking back, over the last four weeks, Demant gained 0.32 percent. Over the last 12 months, its price fell by 11.27 percent. Looking ahead, we forecast Demant A/S to be priced at 245.19 by the end of this quarter and at 234.68 in one year, according to Trading Economics global macro models projections and analysts expectations.